The inclusion in data-driven models of additional easily measurable biomarkers that have already been shown to be helpful in discriminating asthma phenotypes in this population (e.g. serum IgE and/or periostin) [28, 29], combined with comprehensive clinical, physiologic, and/or disease features, might result in the identification of more precise phenotypes. The gene discussed is POSTN; the disease is asthma.